GWP.L Regulatory News (GWP)

13 Feb 2007 09:53

GW Pharmaceuticals PLC13 February 2007 GW Pharmaceuticals plc Response to Market Speculation Porton Down, UK, 13 February 2007 -GW Pharmaceuticals plc (AIM: GWP) notes therecent market speculation regarding discussions with potential US licensingpartners for its lead product, SativexTM. As indicated at the announcement ofits preliminary results on 30 January, GW confirms that these discussions areprogressing in line with the Company's expectations and are proceeding well. Afurther announcement will be made as and when appropriate. Enquiries: Financial Dynamics Tel: +44 (0)20 7831 3113David Yates This information is provided by RNS The company news service from the London Stock Exchange